Relations Between Smoking, Food Intake and Plasma Lipoproteins

  • Anders G. Olsson
  • Jörgen Mölgaard
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)


Smoking is regarded as one of the major risk factors for the development of atherosclerosis together with hyperlipoproteinaemia and hypertension. It has independent power as a risk factor.


Smoking Cessation Plasma Lipoprotein High Density Lipoprotein Cholesterol Level Lipoprotein Lipase Activity Current Cigarette Smoker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yusuf, S. and Furberg, C.O. Single Factor Trials: Control through life style changes. In: Atherosclerosis, Biology and Clinical Science. Editor: Anders G. Olson. Churchill Livingstone, p.390–1 (1987).Google Scholar
  2. 2.
    Billimoria, J.S., Pozner, H., Metselaar, B., Best, F.W. and James, D.L.O. Effects of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human blood. Atherosclerosis, 21:61–76.Google Scholar
  3. 3.
    Olsson, A.G. Studies in asymptomatic primary hyperlipidaemia, Acta Med. Scand. Vol. 197, pp. 477–85 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    Criqui, M.H., Wallace, R.B., Heiss, G., Mishkel, M., Schonfeld, G. and Jones, G.T.L. Cigarette smoking and plasma high density lipoprotein cholesterol, The Lipid Research Clinics Program Prevalence Study, Circulation 62, suppl IV, 70–76 (1980).Google Scholar
  5. 5.
    Stubbe, I., Eskilsson, J. and Nilsson-Ehle, P. High-density lipoprotein concentrations increase after stopping smoking, British Medical Journal, 284:1511–13 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    Stubbe, I. and Nilsson-Ehle, P. Alterations in HDL subfractions and composition after smoking cessation. Relationships to lipoprotein lipase, hepatic lipase and LCAT activities. In Thesis: Coronary Risk Factor Modification by Ingo Stubbe, Studentilitteratur, Lund, pp. 155–84 (1982).Google Scholar
  7. 7.
    Ballantyne, D., Olsson, A.G. and Carlson, L.A. Acute effects of drug therapy in type IV hyperlipoproteinaemia, artery 4(2), 107–28 (1978).Google Scholar
  8. 8.
    Quensel, M., Söderström, A., Agardh, C.D. and Nilsson-Ehle, P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet, Atherosclerosis, 75:189–93 (1989).PubMedCrossRefGoogle Scholar
  9. 9.
    Keys, A., Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, Massachusetts: Harvard Press (1980).Google Scholar
  10. 10.
    Logan, R.L., Thomson, M., Riemersma, R.A. Risk factors for ischaemic heart disease in normal men aged 40, Lancet I, 949–55 (1978).CrossRefGoogle Scholar
  11. 11.
    Wood, D.A., Riemersma, R.A., Butler, S., Thomson, M., Macintyre, C, Elton, R.A. and Oliver, M.F. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease, The Lancet, 1:177–82.Google Scholar
  12. 12.
    Fulton, M., Thomson, M., Elton, R.A., Brown, S., Wood, D.A. and Oliver, M.F. Cigarette smoking, social class and nutrient intake: Relevance to coronary heart disease, European Journal of Clinical Nutrition, 42:797–803 (1988).PubMedGoogle Scholar
  13. 13.
    Riemersma, R. Unpublished.Google Scholar
  14. 14.
    Health and Lifestyle Survey, Preliminary report, p. 98, London: Health Promotion Research Trust (1987).Google Scholar
  15. 15.
    Rubba, P. Personal communication.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Anders G. Olsson
    • 1
  • Jörgen Mölgaard
    • 1
  1. 1.Department of Medicine, Faculty of Health SciencesLinköping University HospitalLinköpingSweden

Personalised recommendations